Wanxing Chai-Ho

Title(s)HS Assistant Clinical Professor, Medicine
SchoolMedicine
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Pivotal Results of SELECT-MDS-1 Phase 3 Study of Tamibarotene with Azacitidine in Newly Diagnosed Higher-Risk MDS. Blood Adv. 2025 May 07. DeZern AE, Thepot S, De Botton S, Patriarca A, Deeren D, Torregrose Diaz JM, Marconi G, Bernal Del Castillo T, Bergua Burgues JM, Xicoy B, Jonasova A, Zeidan AM, Dimicoli-Salazar S, Simand C, Valcárcel D, Díez-Campelo M, Chai-Ho W, Saini L, Garnier A, Geissler K, Ofran Y, Nagy Z, Krishnamurthy P, Lübbert M, Basak GW, Carraway HE, Sallman DA, Borate U, Santini V, Campbell V, Fenaux P, Braun T, Lanza F, Zaucha JM, Roth DA, Paul S, Roy P, Kelly M, Volkert A, Chisolm J, Abdul Malak T, Klimek V, Cluzeau T. PMID: 40334070.
      View in: PubMed   Mentions:    Fields:    
    2. Navigating the peginterferon Alfa-2a shortage: practical guidance on transitioning patients to ropeginterferon alfa-2b. Ann Hematol. 2025 Apr; 104(4):2571-2573. Mesa R, Yacoub A, Tashi T, Chai-Ho W, Yoon CH, Mascarenhas J. PMID: 40178604; PMCID: PMC12052909.
      View in: PubMed   Mentions:    Fields:    
    3. NCCN Guidelines® Insights: Myelodysplastic Syndromes, Version 2.2025. J Natl Compr Canc Netw. 2025 Mar; 23(3):66-75. Greenberg PL, Stone RM, Abaza Y, Al-Kali A, Anand S, Ball B, Bennett JM, Borate U, Brunner AM, Chai-Ho W, Curtin P, DeZern AE, Gaensler K, Gahvari Z, Garcia-Manero G, Griffiths EA, Haque T, Jacoby M, Jonas BA, Keel S, Khanal R, Kishtagari A, Madanat Y, Maness LJ, McCurdy SR, McMahon C, Odenike O, Osman A, Reddy VV, Sallman DA, Sayar H, Shallis R, Singh A, Tanaka T, Thota S, Kovach E, Nguyen J, Hochstetler C. PMID: 40073835.
      View in: PubMed   Mentions:    Fields:    
    4. Allogeneic CD33-directed CAR-NKT cells for the treatment of bone marrow-resident myeloid malignancies. Nat Commun. 2025 Feb 01; 16(1):1248. Li YR, Fang Y, Niu S, Zhu Y, Chen Y, Lyu Z, Zhu E, Tian Y, Huang J, Rezek V, Kitchen S, Hsiai T, Zhou JJ, Wang P, Chai-Ho W, Park S, Seet CS, Oliai C, Yang L. PMID: 39893165; PMCID: PMC11787387.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimals
    5. A phase II study of personalized ultrafractionated stereotactic adaptive radiotherapy for palliative head and neck cancer treatment (PULS-Pal): a single-arm clinical trial protocol. BMC Cancer. 2024 Dec 21; 24(1):1564. Courtney PT, L Santoso M, Savjani RR, K Reddy V, Chai-Ho W, Velez Velez MA, J Wong D, Palodichuk C, Basehart TV, P O'Connell D, Cao M, Telesca D, Chin RK. PMID: 39709372; PMCID: PMC11662514.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    6. Improved Survival of Advanced-Stage Anaplastic Thyroid Cancer With Systemic Therapy. Laryngoscope. 2025 Jan; 135(1):478-484. Evans LK, Chen H, Taki Labib M, Cronkite DA, Yu AC, Ashendouek M, Elashoff D, Chai-Ho W, Wong DJ, St John M. PMID: 39162326; PMCID: PMC11635144.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    7. Tolerability and Efficacy of the Anticluster of Differentiation 47 Antibody Magrolimab Combined With Azacitidine in Patients With Previously Untreated AML: Phase Ib Results. J Clin Oncol. 2023 11 01; 41(31):4893-4904. Daver NG, Vyas P, Kambhampati S, Al Malki MM, Larson RA, Asch AS, Mannis G, Chai-Ho W, Tanaka TN, Bradley TJ, Jeyakumar D, Wang ES, Sweet K, Kantarjian HM, Garcia-Manero G, Komrokji R, Xing G, Ramsingh G, Renard C, Zeidner JF, Sallman DA. PMID: 37703506; PMCID: PMC10617926.
      View in: PubMed   Mentions: 47     Fields:    Translation:HumansCTClinical Trials
    8. Management of Cutaneous Head and Neck Squamous and Basal Cell Carcinomas for Immunocompromised Patients. Cancers (Basel). 2023 Jun 26; 15(13). Bommakanti KK, Kosaraju N, Tam K, Chai-Ho W, St John M. PMID: 37444461; PMCID: PMC10340306.
      View in: PubMed   Mentions:
    9. High Recurrence for HPV-Positive Oropharyngeal Cancer With Neoadjuvant Radiation Therapy to Gross Disease Plus Immunotherapy: Analysis From a Prospective Phase Ib/II Clinical Trial. Int J Radiat Oncol Biol Phys. 2023 10 01; 117(2):348-354. Ma TM, Wong DJ, Chai-Ho W, Mendelsohn A, St John M, Abemayor E, Chhetri D, Sajed D, Dang A, Chu FI, Xiang M, Savjanji R, Weidhaas J, Steinberg ML, Cao M, Kishan AU, Chin RK. PMID: 37141981.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    10. Hierarchical integration of DNA nanostructures and NanoGold onto a microchip facilitates covalent chemistry-mediated purification of circulating tumor cells in head and neck squamous cell carcinoma. Nano Today. 2023 Apr; 49. Sun N, Zhang C, Wang J, Yue X, Kim HY, Zhang RY, Liu H, Widjaja J, Tang H, Zhang TX, Ye J, Qian A, Liu C, Wu A, Wang K, Johanis M, Yang P, Liu H, Meng M, Liang L, Pei R, Chai-Ho W, Zhu Y, Tseng HR. PMID: 38037608; PMCID: PMC10688595.
      View in: PubMed   Mentions: 2  
    11. Excellent Response to Fam-Trastuzumab Deruxtecan for Human Epidermal Growth Factor Receptor 2-Positive Salivary Duct Carcinoma With CNS Metastasis: A Case Report. JCO Precis Oncol. 2022 11; 6:e2200399. Gazola AA, Wong D, Chin R, Nikitas J, Kim CJ, Hart SD, St John M, Chai-Ho W. PMID: 36356285.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    12. NCCN Guidelines® Insights: Myelodysplastic Syndromes, Version 3.2022. J Natl Compr Canc Netw. 2022 02; 20(2):106-117. Greenberg PL, Stone RM, Al-Kali A, Bennett JM, Borate U, Brunner AM, Chai-Ho W, Curtin P, de Castro CM, Deeg HJ, DeZern AE, Dinner S, Foucar C, Gaensler K, Garcia-Manero G, Griffiths EA, Head D, Jonas BA, Keel S, Madanat Y, Maness LJ, Mangan J, McCurdy S, McMahon C, Patel B, Reddy VV, Sallman DA, Shallis R, Shami PJ, Thota S, Varshavsky-Yanovsky AN, Westervelt P, Hollinger E, Shead DA, Hochstetler C. PMID: 35130502.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    13. Allogeneic mesenchymal stromal cell transplantation for systemic sclerosis. Lancet Rheumatol. 2022 Feb; 4(2):e74-e75. Volkmann ER, Chai-Ho W. PMID: 38288739; PMCID: PMC10954215.
      View in: PubMed   Mentions:    Fields:    
    14. Implementing a Tailored Psychosocial Distress Screening Protocol in a Head and Neck Cancer Program. Laryngoscope. 2022 08; 132(8):1600-1608. Brauer ER, Lazaro S, Williams CL, Rapkin DA, Madnick AB, Dafter R, Cheng G, Porter A, Abemayor E, Chai-Ho W, Morasso E, Erman A, Chhetri D, St John M, Wong DJ. PMID: 34953151; PMCID: PMC9875715.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansPHPublic Health
    15. Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar Study. Blood. 2021 12 02; 138(22):2278-2289. Cutler C, Lee SJ, Arai S, Rotta M, Zoghi B, Lazaryan A, Ramakrishnan A, DeFilipp Z, Salhotra A, Chai-Ho W, Mehta R, Wang T, Arora M, Pusic I, Saad A, Shah NN, Abhyankar S, Bachier C, Galvin J, Im A, Langston A, Liesveld J, Juckett M, Logan A, Schachter L, Alavi A, Howard D, Waksal HW, Ryan J, Eiznhamer D, Aggarwal SK, Ieyoub J, Schueller O, Green L, Yang Z, Krenz H, Jagasia M, Blazar BR, Pavletic S. PMID: 34265047; PMCID: PMC8641099.
      View in: PubMed   Mentions: 95     Fields:    Translation:HumansCTClinical Trials
    16. Pembrolizumab plus cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma: an open-label, multi-arm, non-randomised, multicentre, phase 2 trial. Lancet Oncol. 2021 06; 22(6):883-892. Sacco AG, Chen R, Worden FP, Wong DJL, Adkins D, Swiecicki P, Chai-Ho W, Oppelt P, Ghosh D, Bykowski J, Molinolo A, Pittman E, Estrada MV, Gold K, Daniels G, Lippman SM, Natsuhara A, Messer K, Cohen EEW. PMID: 33989559.
      View in: PubMed   Mentions: 110     Fields:    Translation:HumansCTClinical Trials
    17. Clustered incidence of adult acute promyelocytic leukemia. Leuk Res. 2018 11; 74:47-50. Brunner AM, Kim PG, Sadrzadeh H, Drapkin BJ, Sprague KA, Sloan JM, Chai-Ho W, Bhargava P, Pozdnyakova O, Fathi AT. PMID: 30292128.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    18. Paracrine regulation of normal and malignant hematopoiesis. Curr Opin Hematol. 2017 Jul; 24(4):329-335. Chai-Ho W, Chute JP. PMID: 28594661.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    Wanxing's Networks
    Concepts (86)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (33)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCLA Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version UCSF-v3.1.0-12-gbedcc43d on PROFILES-PWEB03. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California